Indivior To Delist From LSE To Better Align With US Focused Business
(RTTNews) - Indivior PLC (INDV.L), a pharmaceutical company, said on Monday that it will cancel its secondary listing on the London Stock Exchange, or LSE, with effect from July 25. The company also noted that it will maintain its current primary listing on the Nasdaq.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
